+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Pharma Hub and Patient Access Support Service Market Size, Share & Trends Analysis Report by Service Type, Service Delivery Type and Region with Growth Forecasts, 2025-2033

  • PDF Icon

    Report

  • 100 Pages
  • November 2025
  • Region: Global
  • Grand View Research
  • ID: 5976495
REQUEST CUSTOMIZATION
Description Jump to:
The global pharma hub and patient access support service market size was estimated at USD 3.24 billion in 2024 and is projected to reach USD 7.63 billion by 2033, growing at a CAGR of 10.0% from 2025 to 2033. The growth is attributed to the increasing need to administer new medicines for various specialties and rare & orphan diseases, prioritizing creating a patient-centric ecosystem.

Payer-side complexity (prior authorizations, specialty drug formularies, and rising claim denials), and tighter affordability controls have pushed manufacturers to outsource patient onboarding, benefiting verification and copay/cost-assistance management to dedicated hub providers.

The growing launch of high-cost specialty and rare-disease therapies between 2021 and 2024 has become a key driver for the expansion of pharma hubs and patient access support services. According to the U.S. FDA, 37 novel drugs were approved in 2022, of which 20 around 54% were targeted at rare diseases, while in 2023, 55 new drugs were approved, and over half, 28 drugs, were for rare diseases. These therapies often carry exceptionally high price tags and require complex insurance approvals.

Hemgenix, a gene therapy for hemophilia B approved in 2022, was priced at about USD 3.5 million per dose, and Alzheimer’s drug Leqembi, approved in 2023, costs around USD 26,500 annually. Such launches highlight the growing financial and administrative barriers for patients, encouraging pharmaceutical companies to invest heavily in digital hub platforms, benefit verification systems, prior authorization automation, and patient support programs. As a result, the increasing number of specialized, high-cost therapies is directly driving demand for integrated pharma hub and patient access support solutions to streamline reimbursement, accelerate therapy initiation, and improve adherence outcomes.

The market is further driven by players undertaking several strategic initiatives. For instance, in November 2023, Docquity announced the expansion of its digitized patient access program, DocquityCare PAP, to Thailand. It launched five PAPs in Thailand, supporting 250 authorized HCPs and around 100 enrolled hospitals to enhance patient care for individuals with cancer and additional life-threatening conditions.

Global Pharma Hub and Patient Access Support Service Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the global pharma HUB and patient access support service market report based on service type, service delivery type, and region:

Service Type Outlook (Revenue, USD Million, 2021-2033)

  • Program Enrollment
  • Treatment Navigators
  • Reimbursement Services/Affordability Services
  • Clinical Educator
  • Coordination of Specialty Pharmacy/Dispensing
  • Others

Service Delivery Type Outlook (Revenue, USD Million, 2021-2033)

  • Integrated Services
  • Standalone Services

Regional Outlook (Revenue, USD Million, 2021-2033)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa (MEA)

Why should you buy this report?

  • Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
  • Competitive Landscape: Explore the market presence of key players.
  • Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
  • Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.

This report addresses:

  • Market intelligence to enable effective decision-making
  • Market estimates and forecasts from 2018 to 2030
  • Growth opportunities and trend analyses
  • Segment and regional revenue forecasts for market assessment
  • Competition strategy and market share analysis
  • Product innovation listings for you to stay ahead of the curve

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Service Type
1.2.2. Service Delivery Type
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising Launch of Specialty and Rare-Disease Therapies
3.2.1.2. Need to Simplify Patient Enrollment and Therapy Access
3.2.1.3. Growing Emphasis on Patient-Centric Care
3.2.1.4. Increasing Regulatory and Compliance Requirements
3.2.2. Market Restraint Analysis
3.2.2.1. High implementation and operational costs
3.2.2.2. Data Privacy and Regulatory Compliance Challenges
3.2.3. Industry Opportunity Analysis
3.2.4. Industry Challenge Analysis
3.2.5. Technology Overview
3.2.6. Case Studies
3.3. Business Environment Analysis
3.3.1. Porter’s Five Forces Analysis
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTLE Analysis
3.3.2.1. Political landscape
3.3.2.2. Economic and Social landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental landscape
3.3.2.5. Legal Landscape
Chapter 4. Pharma HUB and Patient Access Support Service Market: Service Type Estimates & Trend Analysis
4.1. Service Type Segment Dashboard
4.2. Service Type Market Share Movement Analysis, 2024 & 2033
4.3. Market Size & Forecasts and Trend Analysis, by Service Type, 2021 to 2033 (USD Million)
4.4. Program Enrollment
4.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4.2. Order processing
4.4.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4.3. Application processing
4.4.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4.4. Ease of enrollment (through phone, face, portal, or app)
4.4.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.4.5. Program data
4.4.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5. Treatment Navigators
4.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.2. Process flows and standard operating procedures
4.5.2.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.3. Program literature and scripts
4.5.3.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.4. Care team training
4.5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.5.5. Systems testing and optimization
4.5.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.6. Reimbursement Services/Affordability Services
4.6.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.7. Clinical Educator
4.7.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.8. Coordination of Specialty Pharmacy/Dispensing
4.8.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
4.9. Others
4.9.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 5. Pharma HUB and Patient Access Support Service Market: Delivery Type Estimates & Trend Analysis
5.1. Delivery Segment Dashboard
5.2. Delivery Market Share Movement Analysis, 2024 & 2033
5.3. Market Size & Forecasts and Trend Analysis, by Delivery, 2021 to 2033 (USD Million)
5.4. Integrated Services
5.4.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
5.5. Standalone Services
5.5.1. Market Revenue Estimates and Forecasts, 2021-2033 (USD Million)
Chapter 6. Pharma HUB and Patient Access Support Service Market: Regional Estimates & Trend Analysis
6.1. Regional Market Dashboard
6.2. Regional Market: Key Takeaways
6.3. North America
6.3.1. North America Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.3.2. U.S.
6.3.2.1. Key country dynamic
6.3.2.2. Regulatory framework
6.3.2.3. Competitive insights
6.3.2.4. U.S. Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.3.3. Canada
6.3.3.1. Key country dynamic
6.3.3.2. Regulatory framework
6.3.3.3. Competitive insights
6.3.3.4. Canada Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.3.4. Mexico
6.3.4.1. Key country dynamic
6.3.4.2. Regulatory framework
6.3.4.3. Competitive insights
6.3.4.4. Mexico Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4. Europe
6.4.1. Europe Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4.2. Germany
6.4.2.1. Key country dynamic
6.4.2.2. Regulatory framework
6.4.2.3. Competitive insights
6.4.2.4. Germany Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4.3. UK
6.4.3.1. Key country dynamic
6.4.3.2. Regulatory framework
6.4.3.3. Competitive insights
6.4.3.4. UK Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4.4. France
6.4.4.1. Key country dynamic
6.4.4.2. Regulatory framework
6.4.4.3. Competitive insights
6.4.4.4. France Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4.5. Italy
6.4.5.1. Key country dynamic
6.4.5.2. Regulatory framework
6.4.5.3. Competitive insights
6.4.5.4. Italy Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4.6. Spain
6.4.6.1. Key country dynamic
6.4.6.2. Regulatory framework
6.4.6.3. Competitive insights
6.4.6.4. Spain Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4.7. Denmark
6.4.7.1. Key country dynamic
6.4.7.2. Regulatory framework
6.4.7.3. Competitive insights
6.4.7.4. Denmark Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4.8. Sweden
6.4.8.1. Key country dynamic
6.4.8.2. Regulatory framework
6.4.8.3. Competitive insights
6.4.8.4. Sweden Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.4.9. Norway
6.4.9.1. Key country dynamic
6.4.9.2. Regulatory framework
6.4.9.3. Competitive insights
6.4.9.4. Norway Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.5. Asia-Pacific
6.5.1. Asia-Pacific Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.5.2. Japan
6.5.2.1. Key country dynamic
6.5.2.2. Regulatory framework
6.5.2.3. Competitive insights
6.5.2.4. Japan Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.5.3. China
6.5.3.1. Key country dynamic
6.5.3.2. Regulatory framework
6.5.3.3. Competitive insights
6.5.3.4. China Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.5.4. India
6.5.4.1. Key country dynamic
6.5.4.2. Regulatory framework
6.5.4.3. Competitive insights
6.5.4.4. India Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.5.5. South Korea
6.5.5.1. Key country dynamic
6.5.5.2. Regulatory framework
6.5.5.3. Competitive insights
6.5.5.4. South Korea Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.5.6. Australia
6.5.6.1. Key country dynamic
6.5.6.2. Regulatory framework
6.5.6.3. Competitive insights
6.5.6.4. Australia Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.5.7. Thailand
6.5.7.1. Key country dynamic
6.5.7.2. Regulatory framework
6.5.7.3. Competitive insights
6.5.7.4. Thailand Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.6. Latin America
6.6.1. Latin America Pharma HUB and Patient Access Support Service Market Estimates and Forecasts, 2021-2033 (USD Million)
6.6.2. Brazil
6.6.2.1. Key country dynamic
6.6.2.2. Regulatory framework
6.6.2.3. Competitive insights
6.6.2.4. Brazil Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.6.3. Argentina
6.6.3.1. Key country dynamic
6.6.3.2. Regulatory framework
6.6.3.3. Competitive insights
6.6.3.4. Argentina Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.7. MEA
6.7.1. MEA Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.7.2. South Africa
6.7.2.1. Key country dynamic
6.7.2.2. Regulatory framework
6.7.2.3. Competitive insights
6.7.2.4. South Africa Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.7.3. Saudi Arabia
6.7.3.1. Key country dynamic
6.7.3.2. Regulatory framework
6.7.3.3. Competitive insights
6.7.3.4. Saudi Arabia Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.7.4. UAE
6.7.4.1. Key country dynamic
6.7.4.2. Regulatory framework
6.7.4.3. Competitive insights
6.7.4.4. UAE Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
6.7.5. Kuwait
6.7.5.1. Key country dynamic
6.7.5.2. Regulatory framework
6.7.5.3. Competitive insights
6.7.5.4. Kuwait Pharma HUB and Patient Access Support Service market estimates and forecasts, 2021-2033 (USD Million)
Chapter 7. Competitive Landscape
7.1. Participant Overview
7.2. Company Market Position Analysis/Company Market Share Analysis (2024)
7.3. Company Categorization
7.4. Strategy Mapping
7.5. Company Profiles/Listing
7.5.1. Valeris (Formerly PharmaCord)
7.5.1.1. Overview
7.5.1.2. Financial performance
7.5.1.3. Product benchmarking
7.5.1.4. Strategic initiatives
7.5.2. Fortrea
7.5.2.1. Overview
7.5.2.2. Financial performance
7.5.2.3. Product benchmarking
7.5.2.4. Strategic initiatives
7.5.3. AssistRx
7.5.3.1. Overview
7.5.3.2. Financial performance
7.5.3.3. Product benchmarking
7.5.3.4. Strategic initiatives
7.5.4. CareMetx, LLC
7.5.4.1. Overview
7.5.4.2. Financial performance
7.5.4.3. Product benchmarking
7.5.4.4. Strategic initiatives
7.5.5. ConnectiveRx
7.5.5.1. Overview
7.5.5.2. Financial performance
7.5.5.3. Product benchmarking
7.5.5.4. Strategic initiatives
7.5.6. Lash Group
7.5.6.1. Overview
7.5.6.2. Financial performance
7.5.6.3. Product benchmarking
7.5.6.4. Strategic initiatives
7.5.7. McKesson Corporation
7.5.7.1. Overview
7.5.7.2. Financial performance
7.5.7.3. Product benchmarking
7.5.7.4. Strategic initiatives
7.5.8. Engage
7.5.8.1. Overview
7.5.8.2. Financial performance
7.5.8.3. Product benchmarking
7.5.8.4. Strategic initiatives
7.5.9. NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
7.5.9.1. Overview
7.5.9.2. Financial performance
7.5.9.3. Product benchmarking
7.5.9.4. Strategic initiatives
7.5.10. Cardinal Health
7.5.10.1. Overview
7.5.10.2. Financial performance
7.5.10.3. Product benchmarking
7.5.10.4. Strategic initiatives
7.5.11. Envoy Health, Inc.
7.5.11.1. Overview
7.5.11.2. Financial performance
7.5.11.3. Product benchmarking
7.5.11.4. Strategic initiatives
7.5.12. EVERSANA
7.5.12.1. Overview
7.5.12.2. Financial performance
7.5.12.3. Product benchmarking
7.5.12.4. Strategic initiatives
7.5.13. United BioSource LLC
7.5.13.1. Overview
7.5.13.2. Financial performance
7.5.13.3. Product benchmarking
7.5.13.4. Strategic initiatives
7.5.14. Mercalis
7.5.14.1. Overview
7.5.14.2. Financial performance
7.5.14.3. Product benchmarking
7.5.14.4. Strategic initiatives
7.5.15. Sciensus
7.5.15.1. Overview
7.5.15.2. Financial performance
7.5.15.3. Product benchmarking
7.5.15.4. Strategic initiatives
List of Tables
Table 1 List of secodary sources
Table 2 List of abbreviation
Table 3 North America pharma HUB and patient access support service market, by region, 2021-2033 (USD Million)
Table 4 North America pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 5 North America pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 6 U.S pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 7 U.S pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 8 Canada pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 9 Canada pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 10 Mexico pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 11 Mexico pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 12 Europe pharma HUB and patient access support service market, by region, 2021-2033 (USD Million)
Table 13 Europe pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 14 Europe pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 15 Germany pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 16 Germany pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 17 UK pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 18 UK pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 19 France pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 20 France pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 21 Italy pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 22 Italy pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 23 Spain pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 24 Spain pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 25 Denmark pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 26 Denmark pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 27 Sweden pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 28 Sweden pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 29 Norway pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 30 Norway pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 31 Asia-Pacific pharma HUB and patient access support service market, by region, 2021-2033 (USD Million)
Table 32 Asia-Pacific pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 33 Asia-Pacific pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 34 China pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 35 China pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 36 Japan pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 37 Japan pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 38 India pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 39 South Korea pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 40 South Korea pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 41 Australia pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 42 Australia pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 43 Thailand pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 44 Thailand pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 45 Latin America pharma HUB and patient access support service market, by region, 2021-2033 (USD Million)
Table 46 Latin America pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 47 Latin America pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 48 Brazil pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 49 Brazil pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 50 Argentina pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 51 Argentina pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 52 MEA pharma HUB and patient access support service market, by region, 2021-2033 (USD Million)
Table 53 MEA pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 54 MEA pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 55 South Africa pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 56 South Africa pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 57 Saudi Arabia pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 58 Saudi Arabia pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 59 UAE pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 60 UAE pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
Table 61 Kuwait pharma HUB and patient access support service market, by service type, 2021-2033 (USD Million)
Table 62 Kuwait pharma HUB and patient access support service market, by service delivery type, 2021-2033 (USD Million)
List of Figures
Figure 1 Market research process
Figure 2 Data triangulation techniques
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value-chain-based sizing & forecasting
Figure 6 QFD modeling for market share assessment
Figure 7 Market formulation & validation
Figure 8 Pharma HUB and patient access support service market: market outlook
Figure 9 Credentialing software and services competitive insights
Figure 10 Parent market outlook
Figure 11 Related/ancillary market outlook
Figure 12 Penetration and growth prospect mapping
Figure 13 Industry value chain analysis
Figure 14 Pharma HUB and patient access support service market driver impact
Figure 15 Pharma HUB and patient access support service market restraint impact
Figure 16 Pharma HUB and patient access support service market strategic initiatives analysis
Figure 17 Pharma HUB and patient access support service market: Service type movement analysis
Figure 18 Pharma HUB and patient access support service market: Service type outlook and key takeaways
Figure 19 Program enrollment market estimates and forecast, 2021-2033
Figure 20 Order processing market estimates and forecast, 2021-2033
Figure 21 Application processing market estimates and forecast, 2021-2033
Figure 22 Ease of enrollment (through phone, face, portal, or app) market estimates and forecast, 2021-2033
Figure 23 Program data market estimates and forecast, 2021-2033
Figure 24 Treatment navigators market estimates and forecast, 2021-2033
Figure 25 Process flows and standard operating procedures market estimates and forecast, 2021-2033
Figure 26 Program literature and scripts market estimates and forecast, 2021-2033
Figure 27 Care team training market estimates and forecast, 2021-2033
Figure 28 Systems testing and optimization market estimates and forecast, 2021-2033
Figure 29 Reimbursement services/affordability services market estimates and forecast, 2021-2033
Figure 30 Clinical educator market estimates and forecast, 2021-2033
Figure 31 Coordination of specialty pharmacy/dispensing market estimates and forecast, 2021-2033
Figure 32 Others market estimates and forecast, 2021-2033
Figure 33 Pharma HUB and patient access support service market: Service delivery type movement analysis
Figure 34 Pharma HUB and patient access support service market: Service delivery type outlook and key takeaways
Figure 35 Integrated services market estimates and forecast, 2021-2033
Figure 36 Standalone services market estimates and forecast, 2021-2033
Figure 37 Pharma HUB and patient access support service market: Regional movement analysis
Figure 38 Pharma HUB and patient access support service market: Regional outlook and key takeaways
Figure 39 Pharma HUB and patient access support service market share and leading players
Figure 40 North America market share and leading players
Figure 41 Europe market share and leading players
Figure 42 Asia-Pacific market share and leading players
Figure 43 Latin America market share and leading players
Figure 44 Middle East & Africa market share and leading players
Figure 45 North America: SWOT
Figure 46 Europe SWOT
Figure 47 Asia-Pacific SWOT
Figure 48 Latin America SWOT
Figure 49 MEA SWOT
Figure 50 North America, by country
Figure 51 North America
Figure 52 North America market estimates and forecasts, 2021-2033
Figure 53 U.S.
Figure 54 U.S market estimates and forecasts, 2021-2033
Figure 55 Canada
Figure 56 Canada market estimates and forecasts, 2021-2033
Figure 57 Mexico
Figure 58 Mexico market estimates and forecasts, 2021-2033
Figure 59 Europe
Figure 60 Europe market estimates and forecasts, 2021-2033
Figure 61 UK
Figure 62 UK market estimates and forecasts, 2021-2033
Figure 63 Germany
Figure 64 Germany market estimates and forecasts, 2021-2033
Figure 65 France
Figure 66 France market estimates and forecasts, 2021-2033
Figure 67 Italy
Figure 68 Italy market estimates and forecasts, 2021-2033
Figure 69 Spain
Figure 70 Spain market estimates and forecasts, 2021-2033
Figure 71 Denmark
Figure 72 Denmark market estimates and forecasts, 2021-2033
Figure 73 Sweden
Figure 74 Sweden market estimates and forecasts, 2021-2033
Figure 75 Norway
Figure 76 Norway market estimates and forecasts, 2021-2033
Figure 77 Asia-Pacific
Figure 78 Asia-Pacific market estimates and forecasts, 2021-2033
Figure 79 China
Figure 80 China market estimates and forecasts, 2021-2033
Figure 81 Japan
Figure 82 Japan market estimates and forecasts, 2021-2033
Figure 83 India
Figure 84 India market estimates and forecasts, 2021-2033
Figure 85 Thailand
Figure 86 Thailand market estimates and forecasts, 2021-2033
Figure 87 South Korea
Figure 88 South Korea market estimates and forecasts, 2021-2033
Figure 89 Australia
Figure 90 Australia market estimates and forecasts, 2021-2033
Figure 91 Latin America
Figure 92 Latin America market estimates and forecasts, 2021-2033
Figure 93 Brazil
Figure 94 Brazil market estimates and forecasts, 2021-2033
Figure 95 Argentina
Figure 96 Argentina market estimates and forecasts, 2021-2033
Figure 97 Middle East and Africa
Figure 98 Middle East and Africa market estimates and forecasts, 2021-2033
Figure 99 South Africa
Figure 100 South Africa market estimates and forecasts, 2021-2033
Figure 101 Saudi Arabia
Figure 102 Saudi Arabia market estimates and forecasts, 2021-2033
Figure 103 UAE
Figure 104 UAE market estimates and forecasts, 2021-2033
Figure 105 Kuwait
Figure 106 Kuwait market estimates and forecasts, 2021-2033
Figure 107 Market share of key market players- Pharma HUB and patient access support service market

Companies Mentioned

The key companies profiled in this Pharma Hub and Patient Access Support Service market report include:
  • Valeris (Formerly PharmaCord)
  • Fortrea
  • AssistRx
  • CareMetx, LLC
  • ConnectiveRx.
  • Lash Group
  • McKesson Corporation
  • Engage
  • NS Pharma, Inc. (a wholly owned subsidiary of Nippon Shinyaku Co., Ltd.)
  • Cardinal Health
  • Envoy Health, Inc.
  • EVERSANA
  • United BioSource LLC
  • Mercalis
  • Sciensus

Table Information

Report AttributeDetails
No. of Pages100
PublishedNovember 2025
Forecast Period2024 - 2033
Estimated Market Value ( USD ) in 2024 $ 3.24 Billion
Forecasted Market Value ( USD ) by 2033 $ 7.63 Billion
Compound Annual Growth Rate10.0%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Medical Foods Market Size, Share, Trends and Forecast by Product, Route of Administration, Application, Distribution Channel, and Region, 2025-2033 - Product Image

Medical Foods Market Size, Share, Trends and Forecast by Product, Route of Administration, Application, Distribution Channel, and Region, 2025-2033

  • Report
  • 142 Pages
  • Global
From
Healthcare Consulting Services Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033 - Product Image

Healthcare Consulting Services Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2025-2033

  • Report
  • 196 Pages
  • Global
From
Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2025-2033 - Product Image

Hematologic Malignancies Market Report by Type, Therapy, End User, and Region 2025-2033

  • Report
  • 143 Pages
  • Global
From
Pharmaceutical Drugs Market Report 2025 - Product Image

Pharmaceutical Drugs Market Report 2025

  • Report
  • 400 Pages
  • Global
From
Rozanolixizumab (Rystiggo) Market Size, Share & Trends Analysis Report By Indication (Generalized Myasthenia Gravis (gMG), Emerging Pipeline Applications), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033 - Product Image

Rozanolixizumab (Rystiggo) Market Size, Share & Trends Analysis Report By Indication (Generalized Myasthenia Gravis (gMG), Emerging Pipeline Applications), By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.